tiprankstipranks
Trending News
More News >
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Contineum Therapeutics, Inc. Class A (CTNM) Cash flow

Compare
206 Followers

Contineum Therapeutics, Inc. Class A Cash Flow

CTNM's free cash flow for Q3 2025 was $-12.29M. For the 2025 fiscal year, CTNM's free cash flow was decreased by $-52.29M and operating cash flow was $-12.20M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -32.84M$ 19.35M$ -20.12M$ -26.27M
Investing Cash Flow
$ -69.74M$ -65.57M$ 22.30M$ -64.97M
Financing Cash Flow
$ 109.00M$ 56.18M$ -1.24M$ 79.84M
End Cash Position
$ 21.94M$ 15.53M$ 5.57M$ 4.63M
Free Cash Flow
$ -33.36M$ 18.93M$ -20.24M$ -26.43M
Currency in USD

Contineum Therapeutics, Inc. Class A Cash Flow